<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

Eltoprazine hydrochloride - DU 28853

產(chǎn)品貨號

Axon 1142 CAS [98206-09-8] MF C12H16N2O2.HClMW 256.73 Purity: 99% Soluble in water and DMSO Description 5-HT1A/1B agonist and 5-HT2C receptor antagonist. Following L-DOPA challenge, Eltoprazine causes a significant reduction of L-DOPA-induced dyskinesias. References Certificates Categories Extra info G?Griebel et al. Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in mice. Psychopharmacology 1990, 102, 498-502. ? DR. Cherek et al. Acute effects of eltoprazine on aggression and point-mantained responding of normal male participants: Phase I study. Exp. Clin. Psychopharmacol. 1995, 3/3, 287-293. ? P. Svenningsson et al. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study. Brain. 2015 Feb 10. pii: awu409. [Epub ahead of print] Certificate of Analysis Material Safety Data Sheet CNS 5-HT1A 5-HT1B 5-HT2C A19 5-HT1A and 5-HT1B agonist Chemical name 1-(2,3-Dihydro-benzo[1,4]dioxin-5-yl)-piperazine hydrochloride Parent CAS No. [98224-03-4] Order Size Unit Price Stock 10 mg €82.00 In Stock

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

Eltoprazine hydrochloride - DU 28853

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1142

CAS [98206-09-8]

MF C12H16N2O2.HCl
MW 256.73

Purity: 99%
Soluble in water and DMSO

Eltoprazine hydrochloride

Description

5-HT1A/1B agonist and 5-HT2C receptor antagonist. Following L-DOPA challenge, Eltoprazine causes a significant reduction of L-DOPA-induced dyskinesias.

G?Griebel et al. Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in mice. Psychopharmacology 1990, 102, 498-502.

DR. Cherek et al. Acute effects of eltoprazine on aggression and point-mantained responding of normal male participants: Phase I study. Exp. Clin. Psychopharmacol. 1995, 3/3, 287-293.

P. Svenningsson et al. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study. Brain. 2015 Feb 10. pii: awu409. [Epub ahead of print]

Certificate of Analysis
Material Safety Data Sheet

CNS 5-HT1A 5-HT1B 5-HT2C A19

5-HT1A and 5-HT1B agonist

Chemical name

1-(2,3-Dihydro-benzo[1,4]dioxin-5-yl)-piperazine hydrochloride

Parent CAS No.

[98224-03-4]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>